FindTrial
Sign In

Effect of growth factors in uterine lining during in vitro fertilization

Autologous blood cell derivative in thin endometrium in assisted reproductive technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050711
Enrollment
33
Registered
2023-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N972- Female infertility of uterine origin

Interventions

Intervention1: nil: nil

Sponsors

Indrakanti Naga Prathyusha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Thin endometrium patients in frozen embryo transfer cycles 2. Cleavage and blastocyst transfer 3. Basal serum FSH less than 10 IU/l 4. Having a least 1 or 2 good quality frozen embryos

Exclusion criteria

Exclusion criteria: 1. Abnormalities of uterine shape 2. Endometriosis 3. Premature ovarian failure 4. Donor IVF 5. With bleeding disorders

Design outcomes

Primary

MeasureTime frame
1.Endometrial thickness before and after ABCD 2. Uterine biophysical profile before and after ABCDTimepoint: 1. Day of ABCD administration 2. 5 days to 1 weeks after ABCD administration—

Secondary

MeasureTime frame
POSITIVE BETA HCG RATES POSITIVE CLINICAL PREGANANCY RATES POSITIVE LIVE BIRTH RATESTimepoint: 1. 2 weeks after embryo transfer 2. 5 weeks after positive beta hcg 3. 28 -40 weeks after positive clinical pregnancy—

Countries

India

Contacts

Public ContactIndrakanti Naga Prathyusha

Kasturba medical college

anjali.suneel@manipal.edu9686448802

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026